Medline Statistics

Total Valuation

Medline has a market cap or net worth of $58.12 billion. The enterprise value is $69.16 billion.

Market Cap	58.12B
Enterprise Value	69.16B

Important Dates

The next confirmed earnings date is Wednesday, May 6, 2026, before market open.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Medline has 1.31 billion shares outstanding. The number of shares has decreased by -95.36% in one year.

Current Share Class	845.61M
Shares Outstanding	1.31B
Shares Change (YoY)	-95.36%
Shares Change (QoQ)	-95.37%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	30.82%
Float	336.32M

Valuation Ratios

The trailing PE ratio is 30.92 and the forward PE ratio is 30.10. Medline's PEG ratio is 2.77.

PE Ratio	30.92
Forward PE	30.10
PS Ratio	2.04
Forward PS	1.84
PB Ratio	3.35
P/TBV Ratio	n/a
P/FCF Ratio	45.98
P/OCF Ratio	33.32
PEG Ratio	2.77

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.68, with an EV/FCF ratio of 54.71.

EV / Earnings	59.67
EV / Sales	2.43
EV / EBITDA	21.68
EV / EBIT	31.74
EV / FCF	54.71

Financial Position

The company has a current ratio of 4.29, with a Debt / Equity ratio of 0.67.

Current Ratio	4.29
Quick Ratio	2.21
Debt / Equity	0.67
Debt / EBITDA	3.92
Debt / FCF	10.30
Interest Coverage	2.31

Financial Efficiency

Return on equity (ROE) is 6.53% and return on invested capital (ROIC) is 6.44%.

Return on Equity (ROE)	6.53%
Return on Assets (ROA)	3.66%
Return on Invested Capital (ROIC)	6.44%
Return on Capital Employed (ROCE)	6.05%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$631,822
Profits Per Employee	$25,756
Employee Count	45,000
Asset Turnover	0.76
Inventory Turnover	4.53

Taxes

In the past 12 months, Medline has paid $91.00 million in taxes.

Income Tax	91.00M
Effective Tax Rate	7.29%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	45.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	44.44
Average Volume (20 Days)	5,821,135

Short Selling Information

The latest short interest is 18.67 million, so 1.42% of the outstanding shares have been sold short.

Short Interest	18.67M
Short Previous Month	21.94M
Short % of Shares Out	1.42%
Short % of Float	5.55%
Short Ratio (days to cover)	2.66

Income Statement

In the last 12 months, Medline had revenue of $28.43 billion and earned $1.16 billion in profits. Earnings per share was $1.43.

Revenue	28.43B
Gross Profit	7.52B
Operating Income	2.18B
Pretax Income	1.25B
Net Income	1.16B
EBITDA	3.19B
EBIT	2.18B
Earnings Per Share (EPS)	$1.43

Full Income Statement

Balance Sheet

The company has $1.98 billion in cash and $13.01 billion in debt, giving a net cash position of -$11.04 billion or -$8.40 per share.

Cash & Cash Equivalents	1.98B
Total Debt	13.01B
Net Cash	-11.04B
Net Cash Per Share	-$8.40
Equity (Book Value)	19.29B
Book Value Per Share	13.22
Working Capital	8.19B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $1.74 billion and capital expenditures -$480.00 million, giving a free cash flow of $1.26 billion.

Operating Cash Flow	1.74B
Capital Expenditures	-480.00M
Depreciation & Amortization	1.01B
Net Borrowing	-4.13B
Free Cash Flow	1.26B
FCF Per Share	$0.96

Full Cash Flow Statement

Margins

Gross margin is 26.44%, with operating and profit margins of 7.66% and 4.08%.

Gross Margin	26.44%
Operating Margin	7.66%
Pretax Margin	4.39%
Profit Margin	4.08%
EBITDA Margin	11.22%
EBIT Margin	7.66%
FCF Margin	4.45%

Dividends & Yields

Medline does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	95.36%
Shareholder Yield	95.36%
Earnings Yield	1.99%
FCF Yield	2.17%

Analyst Forecast

The average price target for Medline is $50.48, which is 14.11% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$50.48
Price Target Difference	14.11%
Analyst Consensus	Strong Buy
Analyst Count	23
Revenue Growth Forecast (5Y)	8.00%
EPS Growth Forecast (5Y)	11.73%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medline has an Altman Z-Score of 2.27 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.27
Piotroski F-Score	7